CLASS ACTION UPDATE for NLSN, RMTI and GDS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Nielsen Holdings plc (NYSE: NLSN)
Class Period: February 8, 2018 - July 25, 2018
Lead Plaintiff Deadline: October 9, 2018
Join the action: http://www.zlk.com/pslra-d/nielsen-holdings?wire=3 

About the lawsuit: Throughout the class period, Nielsen Holdings plc allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Nielsen disregarded its readiness for and the true risks of privacy related regulations and policies including the European General Data Protection Regulation ("GDPR") on its current and future financial and growth prospects; (2) Nielsen's financial performance was far more dependent on Facebook and other third-party large data set providers than previously disclosed and privacy policy changes affected the scope and terms of access Nielsen would have to third-party data; and (3) access to Facebook and other third-party provider data was becoming increasingly restricted for Nielsen and Nielsen clients.

To learn more about the Nielsen Holdings plc class action contact jlevi@levikorsinsky.com.

Rockwell Medical, Inc. (NASDAQ: RMTI)
Class Period: November 8, 2017 - June 26, 2018
Lead Plaintiff Deadline: September 25, 2018
Join the action: http://www.zlk.com/pslra-d/rockwell-medical-inc?wire=3 

About the lawsuit: During the class period, Rockwell Medical, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Rockwell was aware that The Centers for Medicare and Medicaid Services will not pursue Rockwell’s proposal for separate reimbursement for the drug Triferic; (2) the estimated reserves in the first quarter 2018 10-Q are misstated; (3) there was a material weakness in Rockwell’s internal controls over financial reporting; (4) consequently, Rockwell’s internal controls over financial reporting were ineffective during the Class Period; (5) Defendant Chioini withheld material information regarding Triferic from Rockwell’s auditor, corporate counsel and five independent directors of the Board; and (6) as a result, Defendants’ statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked reasonable bases at all relevant times.

To learn more about the Rockwell Medical, Inc. class action contact jlevi@levikorsinsky.com.

GDS Holdings Limited (NASDAQ: GDS)
Class Period: November 2, 2016 - July 31, 2018
Lead Plaintiff Deadline: October 1, 2018
Join the action: http://www.zlk.com/pslra-d/gds-holdings-limited?wire=3 

About the lawsuit: GDS Holdings Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company has overstated its utilization and occupancy rates; (2) the Company has made acquisitions with related parties at inflated prices; (3) it has used suspect capital and debt raisings despite large off-shore cash reserves; (4) it has adopted unorthodox accounts receivable and payable practices; and (5) that, as a result of the foregoing, Defendant's statements about GDS' business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

To learn more about the GDS Holdings Limited class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com